PMID- 12591112 OWN - NLM STAT- MEDLINE DCOM- 20030702 LR - 20190624 IS - 0014-2999 (Print) IS - 0014-2999 (Linking) VI - 462 IP - 1-3 DP - 2003 Feb 21 TI - Combined action of vasoactive amines and bradykinin mediates allergen-evoked thermal hyperalgesia in rats. PG - 185-92 AB - The ability of allergens to induce hyperalgesia in immunoglobulin E (IgE)-sensitized rats was investigated. The left hind paws of Wistar rats were sensitized with intraplantar injections of IgE anti-dinitrophenylated bovine serum albumin monoclonal antibody, and challenged with dinitrophenylated bovine serum albumin 24 h later. Allergen challenge yielded rapid thermal hyperalgesia and oedema formation in the ipsilateral paws, both reaching a plateau from 15 min to 3 h, and both diminishing thereafter. Allergen-evoked hyperalgesia was inhibited by intraperitoneal treatment with meclizine or methysergide, histamine and 5-hydroxytryptamine receptor antagonists. There was also sensitivity to local treatment with either bradykinin B(1) or B(2) receptor antagonists, des-Arg(9)-[Leu(8)]-bradykinin or D-arginyl-[Hyp3, Thi5, D-Tic7, Oic8]-bradykinin (Hoe 140). Anaphylactic hyperalgesia was mimicked by the combined administration of histamine, 5-hydroxytryptamine and bradykinin at doses which were ineffective when injected alone. This synergistic effect was abolished by treatment with either meclizine, methysergide, Hoe 140 or des-Arg(9)-[Leu(8)]-bradykinin. Our findings show that local thermal hyperalgesia is a feature of allergen-evoked inflammation, and that a synergistic interaction among bradykinin, 5-hydroxytryptamine and histamine plays a critical role in this phenomenon. FAU - Lavich, Tatiana R AU - Lavich TR AD - Departamento de Fisiologia e Farmacodinamica, Instituto Oswaldo Cruz-FIOCRUZ, Av. Brasil 4365, Caixa Postal 926, Rio de Janeiro, Brazil. FAU - Cordeiro, Renato S B AU - Cordeiro RS FAU - Calixto, Joao B AU - Calixto JB FAU - e Silva, Patricia M R AU - e Silva PM FAU - Martins, Marco A AU - Martins MA LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Netherlands TA - Eur J Pharmacol JT - European journal of pharmacology JID - 1254354 RN - 0 (Allergens) RN - 0 (Bradykinin Receptor Antagonists) RN - 0 (Dinitrophenols) RN - 0 (Histamine H1 Antagonists) RN - 0 (Serotonin Antagonists) RN - 27432CM55Q (Serum Albumin, Bovine) RN - 2YHB6175DO (Cyproheptadine) RN - 333DO1RDJY (Serotonin) RN - 37341-29-0 (Immunoglobulin E) RN - 3L5TQ84570 (Meclizine) RN - 64695-06-3 (bradykinin, Leu(8)-des-Arg(9)-) RN - 7PG89G35Q7 (icatibant) RN - 820484N8I3 (Histamine) RN - S8TIM42R2W (Bradykinin) RN - XZA9HY6Z98 (Methysergide) SB - IM MH - Allergens/immunology MH - Animals MH - Bradykinin/*administration & dosage/*analogs & derivatives/pharmacology MH - Bradykinin Receptor Antagonists MH - Cyproheptadine/pharmacology MH - Dinitrophenols/metabolism MH - Dose-Response Relationship, Drug MH - Drug Synergism MH - Edema/chemically induced/prevention & control MH - Histamine/*administration & dosage MH - Histamine H1 Antagonists/pharmacology MH - Hyperalgesia/*chemically induced/immunology/prevention & control MH - Immunoglobulin E/immunology MH - Male MH - Meclizine/pharmacology MH - Methysergide/pharmacology MH - Pain/chemically induced/immunology/prevention & control MH - Rats MH - Rats, Wistar MH - Serotonin/*administration & dosage MH - Serotonin Antagonists/pharmacology MH - Serum Albumin, Bovine/administration & dosage/metabolism MH - Time Factors EDAT- 2003/02/20 04:00 MHDA- 2003/07/03 05:00 CRDT- 2003/02/20 04:00 PHST- 2003/02/20 04:00 [pubmed] PHST- 2003/07/03 05:00 [medline] PHST- 2003/02/20 04:00 [entrez] AID - S0014299902029473 [pii] AID - 10.1016/s0014-2999(02)02947-3 [doi] PST - ppublish SO - Eur J Pharmacol. 2003 Feb 21;462(1-3):185-92. doi: 10.1016/s0014-2999(02)02947-3.